Page last updated: 2024-09-05

ly 300164 and Cerebral Ischemia

ly 300164 has been researched along with Cerebral Ischemia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's6 (85.71)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrási, F; Berzsenyi, P; Hámori, T; Sólyom, S; Tarnawa, I1
Andrási, F; Berzsenyi, P; Erdo, F1
Barkoczy, J; Gigler, G; Gressens, P; Harsing, LG; Kapus, G; Kertesz, S; Levay, G; Medja, F; Spedding, M; Szenasi, G; Villa, P; Williamson, T1
Barkóczy, J; Benedek, A; Gigler, G; Hársing, LG; Lévay, G; Matucz, E; Móricz, K; Szénási, G1
Agoston, M; Albert, M; Barkóczy, J; Benedek, A; Gacsályi, I; Gigler, G; Hársing, LG; Kapus, G; Kertész, S; Lévay, G; Markó, B; Matucz, E; Móricz, K; Simó, A; Szabó, G; Szénási, G; Vegh, M1
Gacsályi, I; Gigler, G; Gyertyán, I; Lévay, G; Szabados, T2

Other Studies

7 other study(ies) available for ly 300164 and Cerebral Ischemia

ArticleYear
Structural analogues of some highly active non-competitive AMPA antagonists.
    Bioorganic & medicinal chemistry letters, 2000, May-01, Volume: 10, Issue:9

    Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Azepines; Behavior, Animal; Benzodiazepines; Brain Ischemia; Cells, Cultured; Chickens; Electroshock; Humans; Mice; Patch-Clamp Techniques; Purkinje Cells; Rats; Receptors, AMPA; Retina; Structure-Activity Relationship

2000
The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia.
    Brain research bulletin, 2005, Jul-15, Volume: 66, Issue:1

    Topics: Animals; Benzodiazepines; Brain Infarction; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Rose Bengal; Tetrazolium Salts; Time Factors

2005
The effects of AMPA receptor antagonists in models of stroke and neurodegeneration.
    European journal of pharmacology, 2005, Sep-05, Volume: 519, Issue:1-2

    Topics: Animals; Animals, Newborn; Anticonvulsants; Benzodiazepines; Brain; Brain Ischemia; Cell Survival; Chickens; Cortical Spreading Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Excitatory Amino Acid Antagonists; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred Strains; Motor Neurons; Nerve Degeneration; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Retina; Seizures; Stroke

2005
Therapeutic time window of neuroprotection by non-competitive AMPA antagonists in transient and permanent focal cerebral ischemia in rats.
    Brain research, 2006, Dec-06, Volume: 1123, Issue:1

    Topics: Animals; Benzodiazepines; Brain Ischemia; Cerebral Cortex; Drug Administration Schedule; Infarction, Middle Cerebral Artery; Male; Neostriatum; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Time Factors

2006
Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models.
    British journal of pharmacology, 2007, Volume: 152, Issue:1

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Benzodiazepines; Brain; Brain Ischemia; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Gerbillinae; Male; Membrane Potentials; Mice; Mice, Inbred DBA; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Purkinje Cells; Quisqualic Acid; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, AMPA; Seizures; Telencephalon; Time Factors

2007
Duration of action of GYKI 52466 and its analogues in antiepileptic, anti-ischaemic and muscle relaxant tests.
    Neurobiology (Budapest, Hungary), 1999, Volume: 7, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Brain Ischemia; Epilepsy; Excitatory Amino Acid Antagonists; Mice; Muscle Relaxants, Central

1999
Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655.
    Brain research bulletin, 2001, Volume: 55, Issue:3

    Topics: Acoustic Stimulation; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Brain Ischemia; Dose-Response Relationship, Drug; Electroshock; Magnesium Chloride; Male; Mice; Mice, Inbred Strains; Neuroprotective Agents; Seizures; Survival Analysis; Time Factors

2001